Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: Elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis

Inflammatory Bowel Diseases

Volumn 11, Issue 1, 2005, Pages 16-23

  Schmidt, Carsten ^a   Giese, Thomas ^b   Ludwig, Bianca ^a   Mueller Molaian, Ina ^a   Marth, Thomas ^c   Zeuzem, Stefan ^a   Meuer, Stefan C ^b   Stallmach, Andreas ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

Crohn's disease; Interleukin 23; Interleukin 27; Real time polymerase chain reaction; Ulcerative colitis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 27; MESSENGER RNA; PROTEIN P19; PROTEIN P28; IL23A PROTEIN, HUMAN; IL27 PROTEIN, HUMAN; INTERLEUKIN 23P19; INTERLEUKIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; COLITIS; COLON MUCOSA; COLONOSCOPY; CONTROLLED STUDY; CORRELATION FUNCTION; CROHN DISEASE; CYTOKINE PRODUCTION; ENTERITIS; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TH1 CELL; ULCERATIVE COLITIS; UPREGULATION; BIOSYNTHESIS; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETICS; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 13944281011     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200501000-00003     Document Type: Article

References (30)

1. Duchmann R, Schmitt E, Knolle P, et al. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol. 1996;26:934-938.
2. Duchmann R, Neurath MF, Meyer zum Buschenfelde KH. Responses to self and non-self intestinal microflora in health and inflammatory bowel disease. Res Immunol. 1997;148:589-594.
3. Zeitz M. Pathogenesis of inflammatory bowel disease. Digestion. 1997;58:59-61.
4. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205.
5. Sartor RB. Pathogenetic and clinical relevance of cytokines in inflammatory bowel disease. Immunol Res. 1991;10:465-471.
6. Gately MK, Renzetti LM, Magram J, et al. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses. Annu Rev Immunol. 1998;16:495-521.
7. Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med. 1989;170:827-845.
8. Wolf SF, Temple PA, Kobayashi M, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol. 1991;146:3074-3081.
9. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by qualitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol. 1995;101:428-435.
10. Fuss IJ, Neurath M, Boirivant M, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996;157:1261-1270.
11. Camoglio L, Te Velde AA, Tigges AJ, et al. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis. 1998;4:285-290.
12. Monteleone G, Biancone L, Marasco R, et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology. 1997;112:1169-1178.
13. Parronchi P, Romagnani P, Annunziato F, et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol. 1997;150:823-832.
14. Berrebi D, Besnard M, Fromont-Hankard G, et al. Interleukin-12 expression is focally enhanced in the gastric mucosa of pediatric patients with Crohn's disease. Am J Pathol. 1998;152:667-672.
15. Pallone F, Monteleone G. Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut. 1992;43:735-736.
16. Omata F, Birkenbach M, Matsuzaki S, et al. The expression of IL-12p40 and its homologue, Epstein-Barr Virus-induced gene 3, in inflammatory bowel disease. Inflamm Bowel Dis. 2001;7:215-220.
17. Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715-725.
18. Parham C, Chirica M, Timans J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J Immunol. 2002;168:5699-5708.
19. Cua DJ, Sherlock J, Chen YI, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003;421:744-748.
20. Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EB13 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity. 2002;16:779-790.
21. Glickman RM. Inflammatory bowel disease: ulcerative colitis and Crohn's disease. In: Fauci AS, Braunwald E, Isselbacher K, et al., eds. Harrison's Principles of Internal Medicine. New York: Me-Graw-Hill, 1998:1633-1645.
22. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology. 1995;108:1617-1621.
23. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearance in proctocolitis. BMJ. 1964;1:89-92.
24. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998;114:262-267.
25. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res. 1996;6:995-1001.
26. Heid CA, Stevens J, Livak KJ, et al. Real time quantitative PCR. Genome Res. 1996;6:986 994.
27. Nieuwenhuis EES, Neurath MF, Corraza N, et al. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc Natl Acad Sci USA. 2002;26:16951-16956.
28. Christ AD, Stevens AC, Koeppen H, et al. An interleakin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn's disease. Gastroenterology. 1998;115:307-313.
29. Desreumaux P, Brandt E, Gambiez L, et al. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology. 1997;113:118-126.
30. Parham C, Chirica M, Timans J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL.23R. J Immunol. 2002;168:5699-5708.